A major breakthrough in cancer study is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This essential malignant inhibitor protein is frequently disabled in several kinds of tumors, causing https://mediasocially.com/story6928712/nanobodies-revive-p53-new-promising-approach-for-cancer-therapy